Perlecan domain I promotes fibroblast growth factor 2 delivery in collagen I fibril scaffolds.
about
Ribozyme-mediated perlecan knockdown impairs chondrogenic differentiation of C3H10T1/2 fibroblasts.Neoproteoglycans in tissue engineeringCan we produce heparin/heparan sulfate biomimetics using "mother-nature" as the gold standard?COOH-terminal collagen Q (COLQ) mutants causing human deficiency of endplate acetylcholinesterase impair the interaction of ColQ with proteins of the basal lamina.Similarity of recombinant human perlecan domain 1 by alternative expression systems bioactive heterogenous recombinant human perlecan D1.Soluble perlecan domain I enhances vascular endothelial growth factor-165 activity and receptor phosphorylation in human bone marrow endothelial cells.Transcriptional activation by NFκB increases perlecan/HSPG2 expression in the desmoplastic prostate tumor microenvironmentNatural marine sponges for bone tissue engineering: The state of art and future perspectives.Perlecan domain 1 recombinant proteoglycan augments BMP-2 activity and osteogenesis.Biomaterials that regulate growth factor activity via bioinspired interactions.Growth factor delivery through self-assembling peptide scaffoldsStrategies for controlled delivery of growth factors and cells for bone regenerationSingle molecule force measurements of perlecan/HSPG2: A key component of the osteocyte pericellular matrix.Heparan sulfate proteoglycans: a GAGgle of skeletal-hematopoietic regulators.Influence of cartilage extracellular matrix molecules on cell phenotype and neocartilage formation.Perlecan domain I-conjugated, hyaluronic acid-based hydrogel particles for enhanced chondrogenic differentiation via BMP-2 release.Mining the extracellular matrix for tissue engineering applications.Recombinant production of proteoglycans and their bioactive domains.Heparan sulfate proteoglycans as key regulators of the mesenchymal niche of hematopoietic stem cells.Repair of cartilage defects in arthritic tissue with differentiated human embryonic stem cells.Engineering and application of collagen-binding fibroblast growth factor 2 for sustained release.A novel peptide sequence in perlecan domain IV supports cell adhesion, spreading and FAK activation.Potential role for heparan sulfate proteoglycans in regulation of transforming growth factor-beta (TGF-beta) by modulating assembly of latent TGF-beta-binding protein-1.Chondrogenic differentiation on perlecan domain I, collagen II, and bone morphogenetic protein-2-based matrices.Pigment epithelium-derived factor (PEDF) shares binding sites in collagen with heparin/heparan sulfate proteoglycans.Injectable perlecan domain 1-hyaluronan microgels potentiate the cartilage repair effect of BMP2 in a murine model of early osteoarthritis.HIP/RPL29 antagonizes VEGF and FGF2 stimulated angiogenesis by interfering with HS-dependent responses.Glycosaminoglycan and Proteoglycan-Based Biomaterials: Current Trends and Future Perspectives.
P2860
Q24540423-787E5B8C-CB45-4F28-867E-4177F789BE1AQ27013763-19F83ACE-1AA6-49CF-B330-766EBBDBC5B8Q27021503-2D8BF239-101C-413F-85EB-2B6937E1E0E0Q33624642-4BC18025-A8C8-4492-977D-254900A41222Q33688591-D3E26FCB-04D3-41A9-BF19-88E8E035D3CEQ33737131-BAE7A175-1AA7-47B8-9F32-25F49A7C1EA5Q33882116-1800F49A-4DF6-46CD-8393-C577E13B9315Q34046824-31AAEFB6-7009-4853-BFC6-01F970F28B1DQ34411156-CBF0BA9F-C0B6-4334-97BB-19C7DB72E766Q35208530-5C24BA5E-FDA1-4004-8846-9525D95A7DA6Q35209334-2F44D8EC-6623-4399-B16B-8A1848841E32Q35981629-71AF49F9-F26B-4FBF-8257-EFC5C6082B09Q36730532-B3942A7E-B3C8-4546-ADA2-BF87359D83D6Q37117272-1CA4EACD-F373-4999-8C9B-2CE26E3D3FBDQ37419263-4CC1346D-18E2-4D2F-ACD9-166207F8A1B1Q37441477-C9D2814A-2302-45BB-8FCF-438EFECFFD52Q37810058-6987EA09-2BCE-426B-A048-F2DB30D02929Q38082553-DD8035B8-D7EF-46EA-9FBA-377D4A206EAFQ38747421-E8F36428-8284-4D99-A43A-0DB5540A4272Q39096793-3EA609CE-F249-4563-8937-7FF4C7880FC8Q39184080-5237B111-174F-493C-BA5D-5A9F789DFEBBQ40053261-8AC680DE-23A4-4A68-9F9C-91671FD13E24Q40117583-3AB3E055-A82F-48FA-B30B-BD55DF82BDA8Q40247376-10C8CD82-F65D-44D5-9AAB-C3B7E0EFD2B5Q41851531-376C6947-FE25-43DD-A9CE-C36255D36A66Q42184028-3ADABDF9-9366-4401-BEEB-CF656C1C26EAQ43096150-C49128C5-3ACF-47DE-B9DA-6056ED35E9A5Q47279130-4E989FC8-4BD0-4A40-9997-DE700AD53B8F
P2860
Perlecan domain I promotes fibroblast growth factor 2 delivery in collagen I fibril scaffolds.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Perlecan domain I promotes fib ...... n collagen I fibril scaffolds.
@en
Perlecan domain I promotes fib ...... n collagen I fibril scaffolds.
@nl
type
label
Perlecan domain I promotes fib ...... n collagen I fibril scaffolds.
@en
Perlecan domain I promotes fib ...... n collagen I fibril scaffolds.
@nl
prefLabel
Perlecan domain I promotes fib ...... n collagen I fibril scaffolds.
@en
Perlecan domain I promotes fib ...... n collagen I fibril scaffolds.
@nl
P2093
P2860
P356
P1433
P1476
Perlecan domain I promotes fib ...... in collagen I fibril scaffolds
@en
P2093
D D Carson
M Alicknavitch
P2860
P356
10.1089/TEN.2005.11.76
P577
2005-01-01T00:00:00Z